Development of a novel microarray methodology for the study of SNPs in the promoter region of the TNF-α gene-Their association with obstructive pulmonary disease in Greek patients

Clinical Biochemistry

Volumn 40, Issue 12, 2007, Pages 843-850

  Papatheodorou, Athanasios ^a   Latsi, Panagiota ^a   Vrettou, Christina ^a   Dimakou, Aikaterini ^b   Chroneou, Alexia ^a   Makrythanasis, Periklis ^a   Kaliakatsos, Marios ^a   Orfanidou, Dora ^a   Roussos, Charis ^a   Kanavakis, Emmanuel ^a   Tzetis, Maria ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Sotiria Chest Diseases Hospital   (Greece)

Author keywords

Chronic Obstructive Pulmonary Disease; Disseminated bronchiectasis; Haplotypes; SNPs; TNF

Indexed keywords

ADULT; AGED; ARTICLE; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SCREENING; GENOTYPE; GREECE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; TRANSCRIPTION INITIATION; TUMOR NECROSIS FACTOR ALPHA GENE;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; ALLELES; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GREECE; HAPLOTYPES; HETEROZYGOTE; HUMANS; MIDDLE AGED; ODDS RATIO; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34447566884     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.03.024     Document Type: Article

References (28)

1. Pauwels R.A., Buist A.S., Calverley P.M., Jenkins C.R., and Hurd S.S. GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI?WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am. J. Respir. Crit. Care Med. 163 (2001) 1256-1276
2. Sandford A.J., and Silverman E.K. Chronic obstructive pulmonary disease. 1: Susceptibility factors for COPD the genotype-environment interaction. Thorax 57 (2002) 736-741
3. Joos L., Pare P.D., and Sandford A.J. Genetic risk factors of chronic obstructive pulmonary disease. Swiss Med. Wkly. 132 (2002) 27-37
4. Luisetti M., Gile L.S., Bombieri C., Benetazzo M.G., and Pignatti P.F. Genetics of chronic obstructive pulmonary disease and disseminated bronchiectasis. Monaldi Arch. Chest Dis. 53 (1998) 614-616
5. Dagli E. Non cystic fibrosis bronchiectasis. Paediatr. Respir. Rev. 1 (2000) 64-70
6. King P., Holdsworth S., Freezer N., and Holmes P. Bronchiectasis. Internal. Med. J. 36 (2006) 729-737
7. Keatings V.M., Collins P.D., Scott D.M., and Barnes P.J. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am. J. Respir. Crit. Care Med. 153 (1996) 530-534
8. Higham M.A., Pride N.B., Alikhan A., and Morrell N.W. Tumour necrosis factor-α gene promoter polymorphism in chronic obstructive pulmonary disease. Eur. Respir. J. 15 (2000) 281-284
9. Huang S.L., Su C.H., and Chang S.C. Tumor necrosis factor-α gene polymorphism in chronic bronchitis. Am. J. Respir. Crit. Care Med. 156 (1997) 1436-1439
10. Patuzzo C., Gile L.S., Zorzetto M., et al. Tumor necrosis factor gene complex in COPD and disseminated bronchiectasis. Chest 117 (2000) 1353-1358
11. Bayley J.P., Ottenhoff T.H.M., and Verweij C.L. Is there a future for TNF promoter polymorphisms?. Genes Immun. 5 (2004) 315-329
12. Cooper K.L., and Goering R.V. Development of a universal probe for electronic microarray and its application in characterization of the Staphylococcus aureus polC gene. J. Mol. Diagn. 5 (2003) 28-33
13. Moutereau S., Narwa R., Matheron C., Vongmany N., Simon E., and Goossens M. An improved electronic microarray-based diagnostic assay for identification of MEFV mutations. Hum. Mutat. 23 (2004) 621-628
14. Sosnowski R.G., Tu E., Butler W.F., O'Connell J.P., and Heller M.J. Rapid determination of single base mismatch mutations in DNA hybrids by direct electric field control. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 1119-1123
15. Evans J.G., and Lee-Tataseo C. Determination of the factor V Leiden single-nucleotide polymorphism in a commercial clinical laboratory by use of NanoChip microelectronic array technology. Clin. Chem. 48 (2002) 1406-1411
16. Erali M., Schmidt B., Lyon E., and Wittwer C. Evaluation of electronic microarrays for genotyping factor V, factor II, and MTHFR. Clin. Chem. 49 (2003) 732-739
17. Stephens M., Smith N.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68 (2001) 978-989
18. Stephens M., and Scheet P. Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am. J. Hum. Genet. 76 (2005) 449-462
19. Shin H.D., Park B.L., Kim L.H., Jung J.H., Wang H.J., Kim Y.J., et al. Association of tumor necrosis factor polymorphisms with asthma and serum total IgE. Hum. Mol. Genet. 13 15 (2004) 397-403
20. Murray C.J., and Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 349 24 (1997) 1498-1504
21. Sakao S., Tatsumi K., Igari H., Shino Y., Shirasawa H., and Kuriyama T. Association of tumor necrosis factor alpha gene promoter polymorphism with the presence of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 163 (2001) 420-422
22. Ishii T., Matsuse T., Teramoto S., et al. Neither IL-1beta, IL-1 receptor antagonist, nor TNF-alpha polymorphisms are associated with susceptibility to COPD. Respir. Med. 94 (2000) 847-851
23. Higuchi T., Seki N., Kamizono S., et al. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 51 (1998) 605-612
24. van Heel D.A., Udalova I.A., De Silva A.P., et al. Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors. Hum. Mol. Genet. 11 15 (2002) 1281-1289
25. Udalova I.A., Richardson A., Denys A., et al. Functional consequences of a polymorphism affecting NF-kappaB p50-p50 binding to the TNF promoter region. Mol. Cell. Biol. 20 (2000) 9113-9119
26. Skoog T., van't Hooft F.M., Kallin B., et al. A common functional polymorphism (C → A substitution at position - 863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum. Mol. Genet. 8 (1999) 1443-1449
27. Zeggini E., Thomson W., Kwiatkowski D., Richardson A., Ollier W., and Donn R. British Paediatric Rheumatology Study Group. Linkage and association studies of single-nucleotide polymorphism-tagged tumor necrosis factor haplotypes in juvenile oligoarthritis. Arthritis Rheum. 46 (2002) 3304-3311
28. Keen-Kim D., Grody W.W., and Richards C.S. Microelectronic array system for molecular diagnostic genotyping: Nanogen NanoChip® 400 and Molecular Biology Workstation. Expert Rev. Mol. Diagn. 6 (2006) 287-294